New ibrutinib combination regimen shows substantial benefits in relapsed chronic lymphocytic leukaemia

Obinutuzumab doubles remission duration in patients with relapsed, indolent non-hodgkin lymphoma

Immunotherapy developments in lung, head and neck, liver and PD-1 repsonse prediction

Pembrolizumab for head and neck cancer

Pembrolizumab shows promising activity against head and neck cancer

New development in metabolic imaging technique with magnetic resonance.

'Liquid biopsy' may help earlier detection of lung cancer treatment resistance

WIN 2015 hosts 'world class leaders' in personalised therapy

WIN 2015: Oncologists and industry working together for personalised medicine

New approaches to diffuse large B-cell lymphoma

Latest in novel approaches to CLL and MCL

Real-world targeted treatment based on whole genome sequencing difficult in pancreatic cancer